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Background and purpose   Patients with fracture of the proximal 
femur often undergo blood transfusion. A pneumatic compres-
sion bandage has been shown to reduce transfusion after primary 
hip arthroplasty for osteoarthritis. In this randomized trial, we 
evaluated the efficacy of this bandage following surgery for hip 
fracture.
Patients and methods   288 patients, 50 years or older with 292 
fractured hips treated with hemiarthroplasty or internal fixation 
(except pinning), were randomized to an experimental group with 
pneumatic wound compression applied after surgery (n = 138) 
and a control group with the same dressing but no compression 
(n = 154). Transfusion threshold was blood hemoglobin below 100 
g/L. The primary outcome measures were the number of blood 
units and the proportion of patients transfused after surgery.
Results   The primary outcome measures were similar in both 
groups. The mean number of postoperatively transfused blood 
units was 1.3 in the compression group and 1.1 in the non-com-
pression group. Blood transfusion was given to 84 patients (62%) 
in the compression group and to 85 patients (55%) in the non-
compression group. 
Interpretation   Pneumatic wound compression does not reduce 
the need for transfusion after hip fracture surgery.

Bleeding from a hip fracture caused by the injury itself and 
by the subsequent surgery often necessitates blood transfu-
sion. To reduce bleeding during and after major orthopedic 
surgery, such as hip and knee arthroplasty, various methods 
(mainly  pharmaceutical)  have  been  investigated  (Keating 
and Meding 2002, Moonen et al. 2006). A pneumatic wound 
compression bandage has been introduced as a new method 
to reduce postoperative bleeding after hip arthroplasty (Hörn-
berg et al. 2002). It was evaluated and found to reduce the 
amount of blood transfusion in two small randomized studies 
on primary total hip arthroplasty (THA) for hip osteoarthritis 
(OA) (Hörnberg et al. 2002, Johansson et al. 2005a). We 
have not found any published studies that used this pneu-
matic compression bandage in patients undergoing surgery 
for hip fracture. The primary objective of this randomized 
controlled trial was therefore to assess the efficacy of the 
pneumatic compression bandage, applied immediately after 
hip fracture surgery, in reducing the need for blood transfu-
sion.
Patients and methods
Patients were recruited at the Emergency Department of Kris-
tianstad Hospital, Sweden, from January 2005 through Decem-
ber 2006. The department provides emergency care for a region 
with a population of 170,000. Patients with a femoral neck frac-
ture, or pertrochanteric or subtrochanteric fracture were screened 
by an orthopedic surgeon for enrollment in the trial. Those who 
fulfilled the eligibility criteria were asked to participate. Written 
informed consent was obtained from all participating patients. 
For patients who could not provide consent themselves because 
of cognitive impairment, the orthopedic surgeon or the ward 
nurse sought consent from a family member. 
Eligibility criteria
The inclusion criteria were patients 50 years or older present-
ing with: (1) displaced cervical femoral fracture planned for 
surgery with hemiarthroplasty, (2) stable pertrochanteric frac-
ture planned for internal fixation with plate and sliding screw 
or twin hook, or (3) unstable pertrochanteric or subtrochanteric 
fracture planned for internal fixation with proximal intramed-
ullary nail. Intracapsular femoral neck fractures treated with 
pinning seldom require transfusion, and they were therefore 
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The exclusion criteria were: (1) undisplaced cervical frac-
ture, (2) displaced cervical fracture planned for fixation with 
hook pins (usually in patients below 75 years of age), (3) 
pathologic fracture due to malignancy, (4) concomitant frac-
tures or injuries that might require blood transfusion, and (5) 
refusal to undergo blood transfusion (such as Jehovah’s Wit-
nesses). 
During  the  study  period,  745  consecutive  patients  with 
proximal femoral fracture were registered at the Emergency 
Department.  Of  333  patients  assessed  for  eligibility,  288 
patients with 292 hip fractures met the inclusion criteria and 
agreed to participate in the study; 138 were randomized to the 
compression group and 154 to the non-compression group.
Surgical procedures
All patients received an intravenous injection of tranexamic 
acid (100 mg/kg body weight) 20 min preoperatively, and a 
second injection after 4 h. All patients were operated on with 
general or spinal anesthesia. 
For hemiarthroplasty, the Lubinus SP II Variokopf (Link, 
Hamburg, Germany) or the Exeter UHR (Stryker Howmed-
ica Osteonics, Exeter, UK) was used. For internal fixation 
of stable pertrochanteric fractures, the Hansson twin-hook 
hip fracture system (Swemac Orthopaedics AB, Linköping, 
Sweden) or the Ambi/Classic compression hip screw system 
(Smith and Nephew, Memphis, TN) was used. For unstable 
pertrochanteric  and  subtrochanteric  fractures,  the  Gamma 
intramedullary  nail  system  (Stryker  Orthopedics,  Mahwa, 
NJ) was used.
The patient was operated upon on a fracture table with lon-
gitudinal traction (internal fixation) or in a lateral decubitus 
position with a dorsolateral approach without trochanter oste-
otomy (hemiarthroplasty). No drain was used. A single dose 
of cloxacillin (2 g intravenously) was given shortly before 
operation (600 mg clindamycin in case of allergy to penicil-
lin). After wound closure, a small dressing was placed over 
the wound. 
Randomization (flow chart)
A randomization list was created based on a computer-gen-
erated random number list. Based on the list, consecutively 
numbered sealed, opaque envelopes were prepared. Patients 
were randomized into 2 groups: an intervention group wear-
ing the bandage with pneumatic pressure applied and a control 
group wearing the bandage but without pressure. Randomiza-
tion of group assignment was done immediately after surgery 
by opening the lowest-numbered envelope.
Sample size
A previous study of 50 patients who had undergone THA for 
OA showed a statistically significant difference of 23% fewer 
transfused patients and 65% less transfused blood units in the 
compression group compared with the non-compression group 
(mean 0.6 units and 1.8 units, respectively, no SDs reported) 
(Hörnberg et al. 2002). In a similar study, the mean number 
of transfused units was 1.4 (SD 1.5) in the compression group 
and 2 (SD 2) in the non-compression group (Johansson et al. 
2005a). Assuming an SD of 1.5, randomization of 280 patients 
would provide 80% power at a 5% 2-sided significance level 
to  detect  differences  of  at  least  0.5  transfused  blood  units 
between the experimental and control groups. This sample size 
would also allow detection of a difference of at least 20% in 
333 Assessed for eligibility
292 Randomized
41 Excluded:
    14 not meeting inclusion criteria
      9 refused
    18 other reasons
154 Allocated to non-intervention:
      149 received allocated non-intervention
          5 did not receive allocated non-intervention
             (no compression bandage available)
138 Allocated to intervention:
      136 received allocated intervention
          2 did not receive allocated intervention
             (1 myocardial infarction, 1 complication 
      with extended operative procedure)
138 Analyzed
    0 Excluded from analysis
154 Analyzed
    0 Excluded from analysis
ENROLLMENT
ALLOCATION
FOLLOW-UP
ANALYSIS
3 Discontinued non-intervention (compression
   applied 3, 6, and 11 hours after surgery
   because of bleeding)
5 Discontinued intervention because of discomfort
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the proportion of transfused patients (assuming a 70% transfu-
sion rate in the control group).
Bandage
The pneumatic compression bandage, Calmed compression 
dressing system (Calmar Medical AB, Askim, Sweden), was 
applied when the patient was being moved from the opera-
tion table to a bed. The bandage consists of a garment placed 
around the hip region and an inflatable bag placed directly over 
the postoperative dressing on the surgical incision (Figure). 
In  patients  randomized  to  the  compression  group,  air  was 
pumped into the bag. The initial pressure of 40 mm Hg was 
maintained for 30 min, after which the pressure was lowered 
to 20 mm Hg and kept for 12 h. In patients randomized to the 
control group, the bandage was applied in an identical manner 
but the bag was not inflated.
Postoperative care 
The postoperative care followed routine clinical care. A daily 
subcutaneous injection of 40 mg enoxaparin was given for 10 
days. Early mobilization with weight bearing as tolerated was 
allowed from the first postoperative day.
Transfusion
A transfusion of 1 red cell unit was given when blood hemo-
globin (Hb) was below 100 g/L, and repeated when necessary 
using the same threshold. 
Assessments 
At baseline, data concerning preoperative use of medication 
with  antithrombotic  effect,  including  warfarin,  acetylsali-
cylic acid (ASA), or other anti-platelet drugs or non-steroi-
dal anti-inflammatory drugs (NSAIDs), were recorded. Time 
from  arrival  at  the  Emergency  Department  to  surgery  was 
recorded. Blood Hb, platelet count, international normalized 
ratio (INR), and activated partial thromboplastin time (APT-t) 
were measured at admission. Blood Hb was routinely mea-
sured 3 h after surgery and on postoperative days 1 and 5. 
Further Hb measurements were made on clinical suspicion of 
low Hb, if the Hb value was close to the transfusion thresh-
old, or if blood had been transfused. Intraoperative blood loss 
was estimated by the nurse anesthetist by counting wet swabs 
and drapes together with suction volume minus volume of any 
irrigation fluid used. The number of red cell units transfused 
before, during, and after surgery (up to discharge from hospi-
tal or death) was recorded. Potential complications related to 
the bandage—including pressure ulcers, deep vein thrombosis 
and pulmonary embolism, and wound complications (delayed 
healing, necrosis, rupture or infection)—were recorded up to 
3 months after surgery. The dressing was inspected daily by 
ward nurse assistants and the surgical wound was routinely 
inspected on day 5, on the day of discharge, and when the 
sutures were removed 2 weeks postoperatively. Data for all 
treated infections or positive cultures up to three months post-
operatively were recorded by a nurse in a centralized hospital 
database. Pre-existing or new pressure ulcers were looked for 
and documented daily by ward nurse assistants on a special 
form. Clinically suspected deep vein thrombosis was exam-
ined with venography or ultrasound, and pulmonary embolism 
with spiral computerized tomography of the chest.
Outcome measures 
The primary outcome measure was the mean number of red 
cell  units  transfused  postoperatively  and  the  proportion  of 
patients in each group requiring postoperative blood transfu-
sion. The secondary outcome measure was the rate of postop-
erative complications.
Ethics
The study was approved by the Medical Research Ethics Com-
mittee of Lund University (704/2004-11-30).
Statistics
Intention-to-treat  analyses  were  performed.  The  mean  dif-
ference and 95% CI in number of postoperatively transfused 
blood units was compared between the 2 groups using the 
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independent-samples t-test. Difference between the 2 groups 
in the proportion of postoperatively transfused patients was 
analyzed using a logistic regression. Analyses adjusting for 
age, sex, use of drugs with antithrombotic effect and NSAIDs, 
baseline hemoglobin, type of surgery, number of blood units 
transfused before and/or during surgery, and amount of intra-
operative bleeding gave similar results, and therefore the unad-
justed results have been used. Similar analyses were done after 
stratifying the patients according to type of surgery. Because 4 
patients had been enrolled twice, as they had a subsequent frac-
ture of the contralateral hip during the study period, a mixed-
effects model analysis was performed to validate the results of 
the t-test and regression analyses. Complications were com-
pared. The 30-day and 90-day mortality rates were compared 
between the groups. All analyses were two-sided and a p-value 
of < 0.05 was considered to indicate statistical significance.
Results
Patients
Most of the 288 patients (with 292 fractures) received the allo-
cated intervention, but 3 patients assigned to non-compression 
(1 hemiarthroplasty and 2 intramedullary nail) received com-
pression ordered by the anesthesiologist because of “excessive 
bleeding” and 5 patients assigned to compression (1 hemiar-
throplasty, 4 sliding plate) removed the bandage because of 
discomfort or confusion after 1, 7, 8, and 10 hours (the time 
was not recorded for 1 patient). There were no differences 
between the 2 groups regarding their baseline characteristics 
(Table 1).
Blood transfusion
No statistically significant differences were found between the 
2 groups with regard to the mean number of postoperatively 
transfused  units,  or  in  the  proportion  of  patients  requiring 
blood transfusion (Table 2). The mixed-effects model analy-
sis gave similar results, with a mean difference in number of 
postoperatively transfused units of 0.17 (95% CI: -0.13 0.46, 
p = 0.3) and an odds ratio of having postoperative transfusion 
of 1.69 (95% CI: 0.5–5.7, p = 0.4). No differences were found 
between the 2 groups when stratified according to type of sur-
gery (Table 3).
Complications and mortality
No  differences  in  complications  or  mortality  were  found 
between the 2 groups. Superficial wound infection occurred in 
6 patients (4.3%) in the compression group and 8 (5.2%) in the 
non-compression group; all healed without treatment, or with 
antibiotics. No deep wound infections occurred. 1 patient in the 
non-compression group had a minor wound rupture that healed 
without surgery. Another patient in the non-compression group 
developed a blister near the surgical wound, recorded as a com-
Table 1. Baseline characteristics
    No
  Compression  compression
  (n = 138)  (n = 154)
Age    83 (9)    82 (8)
Women, n (%)  100 (72)  113 (73)
Type of fracture, n (%)
  Cervical     55 (40)    68 (44)
  Pertrochanteric     63 (46)    75 (49)
  Subtrochanteric     20 (14)    11 (7)
Type of surgery, n (%)
  Hemiarthroplasty    45 (33) a    60 (39)
  Sliding plate    42 (30)    50 (32)
  Intramedullary nail    51 (37)    44 (29)
Preoperative medication, n (%)
  Acetylsalicylic acid     65 (47)    64 (42)
  NSAID      8 (5.8)      6 (3.9)
  Warfarin    11 (8.0)    13 (8.4)
Time from admission to surgery (h) b    21 (11)    21 (12)
Hemoglobin (g/L) at baseline  124 (15)  126 (15)
Patients transfused
    preoperatively, n (%)    20 (15)    21 (14)
  intraoperatively, n (%)     47 (34)    45 (29)
Bleeding intraoperatively (mL)  351 (292)  325 (275)
  Hemiarthroplasty  462 (186) a  418 (251)
  Sliding plate  193 (142)  148 (85)
  Intramedullary nail  383 (393)  398 (349)
Values are shown as mean (SD) unless otherwise specified.
a Including 1 total arthroplasty.
b No data were available for 14 patients in the compression group 
  and for 13 patients in the non-compression group.
Table 2. Results of the outcome variables
    No    
  Compression  compression  Mean difference or  p-value
  (n =138)  (n = 154)  odds ratio (95% CI)
Blood units transfused postoperatively    1.3 (1.3)   1.1 (1.3)  0.17 (-0.13–0.46)  0.3
Patients transfused postoperatively, n (%)    85 (62)    84 (55)  1.34 (0.84–2.13)  0.2
Hemoglobin day 1 (g/L)  109 (10.3)  109 (11.2)    0.5 (-0.2–0.3)  0.7
Hemoglobin day 5 (g/L)  111 (9.7) a  113 (10.1) a   -2.1 (-4.4–0.3)  0.08
Data are shown as mean (SD) unless otherwise specified.
a No data were available for 7 patients in the compression group and for 6 in the non-compression group.30  Acta Orthopaedica 2009; 80 (1): 26–31
plication to the bandage. Sacral pressure ulcers were registered 
in 4 patients in the compression group and in 5 in the non-
compression group. Deep vein thrombosis was diagnosed in 
2 patients in each group and pulmonary embolism was diag-
nosed in 2 patients in the compression group.
The 30-day mortality was 8% in the compression group 
(n = 11) and 6.5% in the non-compression group (n = 10), 
and the 90-day mortality was 10% (n = 14) and 12% (n = 18), 
respectively. 7 patients died during the primary hospital stay, 
with the causes of death being cerebral embolism, myocar-
dial infarction, heart failure, pulmonary edema, kidney failure, 
pneumonia, or septicemia. For the patients who died after dis-
charge, the cause of death was not ascertained. 
Discussion
The compression bandage evaluated in our study has previ-
ously been reported to be effective in reducing the need for 
transfusion, but not the blood loss, following THA in patients 
with OA (Hörnberg et al. 2002, Johansson et al. 2005a). The 
former study compared 26 patients who received the compres-
sion bandage with 24 patients who received a standard wound 
dressing, and reported a significantly reduced amount of post-
operative blood transfusion and a significantly reduced pro-
portion of transfused patients in the compression group (Hörn-
berg et al. 2002). The later study compared 51 patients who 
had the compression bandage and no wound drainage with 54 
patients who had a standard dressing and wound drainage, and 
it reported a significantly reduced amount of blood transfu-
sion in the compression group but not a reduced proportion of 
transfused patients (Johansson et al. 2005a).
We could not demonstrate that the compression bandage 
was similarly effective after hip fracture surgery. One possible 
explanation is that OA patients and hip fracture patients differ 
in important factors such as age, body mass, general health 
status, and medications. It is common to advise OA patients to 
stop intake of drugs known to increase bleeding (such as ASA 
and NSAIDs) before surgery (Faunö et al. 1993, Hörnberg et 
al. 2002, Johansson et al. 2005b). In the present study, there 
were no differences between groups regarding the use of such 
drugs before surgery. In fracture patients, preoperative bleed-
ing from the fracture itself can be considerable—a factor that 
is not influenced by the compression bandage. 
The two studies that reported an advantage in using the 
compression bandage in THA used wound drain, either in 
both  groups  (Hörnberg  et  al.  2002)  or  only  in  the  control 
group (Johansson et al. 2005a). Wound drain was, however, 
not used in our study and it is currently not commonly used 
after hip arthroplasty (Niskanen et al. 2000) or hip fracture 
surgery (Tjeenk et al. 2005) since neither the blood loss nor 
the wound infection rates are affected. The study by Hörnberg 
et al. (2002) was relatively small and did not adjust for other 
differences, possibly resulting in a type-1 error. The study by 
Johansson et al. (2005a) reported somewhat conflicting find-
ings: a reduction in the mean number of transfused units but 
not in the number of patients transfused. In the light of our 
results, a larger randomized study may be warranted to con-
firm the efficacy of the compression bandage in patients under-
going primary THA for OA. However, in hip fracture surgery, 
our results from a large sample size did not show any evidence 
to suggest that the compression bandage may be effective. We 
used intention-to-treat analysis but only 3 patients randomized 
to the non-compression group received compression, so this 
cannot have influenced the results. In our study, we used the 
pressure levels and application time proposed by the manufac-
turer and used by Hörnberg et al. (2002), but somewhat shorter 
than the application time used by Johansson et al. (2005a). It 
is not known whether a higher pressure level and/or a longer 
application time might be more effective.
One limitation of our study is that many eligible patients 
were not enrolled because of difficulty in obtaining consent, 
or because they were not asked to participate by the surgeon at 
the Emergency Department. Many patients suffer from demen-
tia and/or confusion on admission and are therefore incapable 
of giving informed consent, and it was not always possible to 
contact a family member. However, it seems very unlikely that 
this factor would have influenced the results. 
To determine the need for blood transfusion, we used Hb 
below 100 g/L. This transfusion threshold has been used in 
Table 3. Results of the primary outcome variables stratified according to surgical method
Blood transfusion  Compression  No compression  Mean difference or  p-value
postoperatively  (n = 138)  (n = 154)  odds ratio (95% CI)
Blood units, mean (SD)
  Hemiarthroplasty  n=45 a  0.87 (1.2)  n=60  0.83 (1.2)  0.03 (-0.5–0.5)  0.9
  Sliding plate  n=42  1.10 (1.3)  n=50  0.98 (1.1)  0.1 (-0.4–0.6)  0.7
  Intramedullary nail  n=51  1.82 (1.2)  n=44  1.68 (1.3)  0.1 (-0.4–0.7)  0.6
Patients, n (%)
  Hemiarthroplasty   n=45 a  20 (44)  n=60  26 (43)  1.1 (0.48–2.3)  0.9
  Sliding plate  n=42  22 (52)  n=50  25 (50)  1.1 (0.48–2.5)  0.8
  Intramedullary nail  n=51  43 (84)  n=44  33 (75)  1.8 (0.65–5.0)  0.3
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some studies (Anekstein et al. 2004, Muir 1995) but other 
studies have used lower thresholds of 70–90 g/L (Marval and 
Hardman 2004). One pilot study randomized 84 patients with 
hip fracture to receive transfusion if Hb levels dropped below 
the predefined threshold of 100 g/L, or to receive transfusion 
only for symptoms of anemia or a Hb of less than 80 g/L, but 
no firm conclusions could be drawn from that study (Carson et 
al. 1998b). Consequently, there is a lack of evidence on which 
to base the transfusion threshold following hip fracture sur-
gery. In the 2 studies with pneumatic wound compression in 
OA patients, Hörnberg et al. (2002) used a transfusion thresh-
old of Hb below 100 g/L and Johansson et al. (2005a) used 
Hb below 90 g/L or “symptoms of anemia requiring transfu-
sion”. Many authors have advocated lower thresholds (Carson 
et al 1998a, Madjdpour et al. 2006). Using a lower transfusion 
threshold in our study would have resulted in fewer transfused 
patients and a lower amount of transfusions in both groups, 
but it is unlikely that this would have influenced the results 
regarding the efficacy of the compression bandage.
Pressure applied to the surgical wound could theoretically 
give rise to local skin ischemia and thereby increase the risk 
of delayed healing, wound rupture, necrosis, or infection. In a 
study of 965 cervical hip fractures, wound infection occurred 
in 7% of patients receiving blood transfusion and in 4% of 
those  not  receiving  blood  transfusion  (Levi  and  Sandberg 
1998). In our study, the rate of superficial wound infection was 
5%, which is in agreement with previous studies (Merrer et 
al. 2007), with no difference found between the compression 
and control groups. One other potential complication of using 
a compression bandage is the occurrence of pressure ulcers. 
However, both groups had equal amounts of sacral pressures 
and no patient developed ulcers on either hip. Compression 
around the hip region might theoretically cause venous stasis 
and increased risk of thromboembolic events. According to a 
Cochrane review, deep vein thrombosis occurs in up to 26% 
of  patients  following  hip  fracture  surgery,  despite  prophy-
laxis with LMWH (Handoll et al. 2002). In our study, clinical 
thromboembolic complications occurred in 3.6% of patients 
in the compression group, which is a relatively low rate. 
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